1. Volume 141, Issue 2, Pages 442-450 (February 2012)
Risk Factors and Outcome of Pulmonary Complications After Autologous Hematopoietic Stem Cell Transplant 
Bekele Afessa, MD, FCCP, Raolat M. Abdulai, MD, Walter K. Kremers, PhD, William J. Hogan, MB, Mark R. Litzow, MD, Steve G. Peters, MD, FCCP 
CHEST 
Volume 141, Issue 2, Pages (February 2012)
DOI: /chest
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

2. Figure 1
Diagnostic approach of the HSCT recipient with pulmonary symptoms and/or signs. HRCT = high-resolution CT; PFT = pulmonary function test; TBB = transbronchial lung biopsy; VATS = video-assisted thoracoscopic surgery.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

3. Figure 2
Cumulative incidence of bacterial, fungal, and viral pulmonary complications.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

4. Figure 3
Cumulative incidence of selected noninfectious complications. APE = acute pulmonary edema; DAH = diffuse alveolar hemorrhage; IPS = idiopathic pneumonia syndrome; PERDS = peri-engraftment respiratory distress syndrome.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

5. Figure 4
Patient survival following hematopoietic stem cell transplant. PC = pulmonary complication.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions